Literature DB >> 2642698

Characterization of HTLV-I in a T-cell line established from a patient with myelopathy.

T Nakamura1, M Tsujihata, S Shirabe, H Matsuo, Y Ueki, S Nagataki.   

Abstract

We have established an interleukin 2-dependent, OKT4-positive T-cell line, named HCT-1, from cells in the cerebrospinal fluid obtained from a patient with human T-cell lymphotropic virus type I (HTLV-1)-associated myelopathy. Antigens for HTLV-I were detected in HCT-1 cells by indirect immunofluorescence and Western blot testing, and type C virus particles were detected by electron microscopy. Southern blot analysis of HCT-1 cellular DNA, using an HTLV-I probe, revealed that the integrated provirus genome could not be distinguished from the HTLV-I genome in adult patients with T-cell leukemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642698     DOI: 10.1001/archneur.1989.00520370037015

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

1.  Search for human T-cell leukemia virus type I (HTLV-I) proviral sequences by polymerase chain reaction in the central nervous system tissue of HTLV-I-associated myelopathy.

Authors:  Y Ohara; Y Iwasaki; S Izumo; I Kobayashi; A Yoshioka
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  An autopsy case of human T lymphotropic virus type I-associated myelopathy (HAM) with a duration of 28 years.

Authors:  S Sasaki; T Komori; S Maruyama; M Takeishi; Y Iwasaki
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  HTLV-I associated arthritis: characteristics of an HTLV-I virus infected T cell line from synovial fluid.

Authors:  K Eguchi; T Nakamura; M Mine; H Ida; A Kawakami; K Migita; K Nagasato; A Kurata; T Fukuda; S Nagataki
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

4.  Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-κB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells.

Authors:  Yanuar Rahmat Fauzi; Shingo Nakahata; Syahrul Chilmi; Tomonaga Ichikawa; Phawut Nueangphuet; Ryoji Yamaguchi; Tatsufumi Nakamura; Kazuya Shimoda; Kazuhiro Morishita
Journal:  PLoS One       Date:  2021-08-18       Impact factor: 3.240

5.  Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells.

Authors:  M Sakai; K Eguchi; K Terada; M Nakashima; I Yamashita; H Ida; Y Kawabe; T Aoyagi; H Takino; T Nakamura
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

6.  Tocilizumab has no direct effect on cell lines infected with human T-cell leukemia virus type 1.

Authors:  Yushiro Endo; Shoichi Fukui; Tomohiro Koga; Daisuke Sasaki; Hiroo Hasegawa; Katsunori Yanagihara; Akihiko Okayama; Tatsufumi Nakamura; Atsushi Kawakami; Hideki Nakamura
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.